Search company, investor...

Avestha Gengraine Technologies

Founded Year



Unattributed | Alive

About Avestha Gengraine Technologies

Avestha Gengraine Technologies is a biotechnology & bioinformatics company, focusing on the convergence between food, pharmaceuticals and clinical genomics leading to preventive personalized medicine. . Avesthagen was founded by Dr. Villoo Morawala-Patell in 1998, on the premise that the time was ripe for India to establish its own research and discovery based biotechnology industry. Avesthagen aims to provide solutions for global challenges in agriculture & health problems in the areas of degenerative conditions, metabolic disorders and infectious diseases.

Headquarters Location

Discoverer 9th Floor, International Technology Park, Whitefield Road



Missing: Avestha Gengraine Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Avestha Gengraine Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Avestha Gengraine Technologies Patents

Avestha Gengraine Technologies has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Cell biology, Plant physiology, Herbicides, Antioxidants, Free radicals


Application Date


Grant Date



Related Topics

Cell biology, Plant physiology, Herbicides, Antioxidants, Free radicals



Avestha Gengraine Technologies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Avestha Gengraine Technologies Rank

Avestha Gengraine Technologies Frequently Asked Questions (FAQ)

  • When was Avestha Gengraine Technologies founded?

    Avestha Gengraine Technologies was founded in 1998.

  • What is Avestha Gengraine Technologies's latest funding round?

    Avestha Gengraine Technologies's latest funding round is Unattributed.

  • Who are the investors of Avestha Gengraine Technologies?

    Investors of Avestha Gengraine Technologies include ICICI Venture, bioMerieux, Vilmorin Clause & Cie, Limagrain, Tata Group and 6 more.

  • Who are Avestha Gengraine Technologies's competitors?

    Competitors of Avestha Gengraine Technologies include Aerie, Bone Biologics, Hawaii Biotech, Array Biopharma, NGM Biopharmaceuticals and 14 more.

Compare Avestha Gengraine Technologies to Competitors

Genaissance Pharmaceuticals

Personalized medicine through population genomics and informatics.

Biolog Logo

Biolog specializes in microbial identification, phenotypic cell profiling, and metabolic fingerprinting for microbial and mammalian cells. The company’s products enable the identification of thousands of species of bacteria, yeast, and fungi, as well as the characterization of human cells and mitochondria. Biolog's products are available worldwide, either directly from the company or through its extensive network of international distributors. The company was founded in 1984 and is based in Hayward, California.

Arcion Therapeutics

Arcion Therapeutics applies breakthroughs in neuroscience to advance the treatment of chronic pain. The company focuses on topical treatments to provide pain relief with convenient application and reduced systemic side effects. Arcion's core technology is based on research which showed that in many neuropathic pain conditions, the signal that triggers pain actually arises at the level of the skin. This finding provides a strong biological rationale for developing topically delivered drugs to target the pain at the source - the pain receptors in the skin. Arcion's product pipeline comprises multiple candidates to treat neuropathic pain.ARC-4558 is a topical 0.1% clonidine gel being developed for the treatment of painful diabetic neuropathy (PDN). It is a clear, water-based, fast-drying gel that provides pain relief that rivals approved oral drugs. ARC-4558 has a minimal side-effect profile with low/undetectable systemic levels of clonidine with over 600 patients treated in clinical trials to date.

Chroma Therapeutics

Chroma Therapeutics is a biotechnology company founded to exploit the potential of chromatin biology for cancer drug discovery. Chroma is focused on the identification of anti-cancer agents that combine the efficacy of cytotoxics with the tumour cell selectivity of modern targeted therapeutics. Based in Oxford, UK, Chroma is developing a pipeline of anti-cancer drugs.


is a contract research organization that collaborates with R&D departments of biotechnology and biopharmaceutical companies to discover and develop new medicines. The company also engages in its own drug discovery agenda to develop treatments of treat tropical diseases such as malaria.

Hawaii Biotech

Hawaii Biotech (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. Lead vaccine candidates in clinical development target the West Nile virus and Dengue virus. Additional recombinant protein subunits vaccine candidates produced from this protein production platform are currently under development.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.